Aliskiren

Aliskiren

SCHEMBL2478013

COCCCOc1cc(CC(CC(N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

REN

The experimentally established mechanism targets of Aliskiren. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN known ✓ P00797 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aliskiren SCHEMBL3476540 1.00 REN (1.00) REN
Aliskiren SCHEMBL3397036 1.00 REN (1.00) REN
Aliskiren SCHEMBL29521564 1.00 REN (1.00) REN
Aliskiren SCHEMBL455490 1.00 REN (1.00) REN
Aliskiren SCHEMBL3476535 1.00 REN (1.00) REN
Aliskiren SCHEMBL3476537 1.00 REN (1.00) REN
Aliskiren SCHEMBL13320734 1.00 REN (1.00) REN
Aliskiren SCHEMBL13351616 1.00 REN (1.00) REN
Aliskiren SCHEMBL7965529 1.00 REN (1.00) REN
Aliskiren SCHEMBL6854403 1.00 REN (1.00) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373306-A1 TRANSDERMALLY ADMINISTERED ALISKIREN Merck Canada Inc. (CA) 2011-10-12 EP disclosed
WO-2010060199-A1 TRANSDERMALLY ADMINISTERED ALISKIREN MERCK FROSST CANADA LTD. (CA) 2010-06-03 WO disclosed